Article info

Download PDFPDF
Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson’s disease

Authors

  • Dag Aarsland Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK Mental Health of Older Adults and Dementia Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Anto P Rajkumar Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK Mental Health of Older Adults and Dementia Clinical Academic Group, South London and Maudsley NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Abdul Hye Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Dag Aarsland, Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 16, De Crespigny Park, London SE5 8AF, UK; dag.aarsland{at}kcl.ac.uk
View Full Text

Citation

Aarsland D, Rajkumar AP, Hye A
Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson’s disease

Publication history

  • Received May 5, 2017
  • Accepted May 17, 2017
  • First published June 12, 2017.
Online issue publication 
September 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.